劉壽鍾
Department
消化内科
脏器移植中心
肝癌中心 消化内科
癌症个体化治疗中心 消化内科
Specialty
网上预约
Liver cancer
,
Hepatocellular carcinoma
,
Liver fibrosis
,
Cirrhosis
,
Liver transplantation
,
hepatitis
,
Fatty liver
Liver transplantation
Liver cancer
,
Hepatocellular carcinoma
,
Liver fibrosis
,
Cirrhosis
,
Liver transplantation
Liver cancer
,
Confirmation of liver cancer
,
Suspicion of liver cancer
Education / Career
| Article | Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma | ||
|---|---|---|---|
| Announcements | Journal of Hepatology | Date of publication | 2019-03 |
| Co-researcher | Yu SJ, Ma C, Heinrich B, Brown ZJ, Sandhu M, Zhang Q, Fu Q, Agdashian D, Rosato U, Korangy F, Greten TF | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/30414862/ | ||
| ETC URL | https://www.ncbi.nlm.nih.gov/pubmed/30414862 | ||
| Article | Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma | ||
|---|---|---|---|
| Announcements | Hepatology | Date of publication | 2017-09 |
| Co-researcher | Won JK, Yu SJ, Hwang CY, Cho SH, Park SM, Kim K, Choi WM, Cho H, Cho EJ, Lee JH, Lee KB, Kim YJ, Suh KS, Jang JJ, Kim CY, Yoon JH, Cho KH | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/28439950/ | ||
| ETC URL | https://www.ncbi.nlm.nih.gov/pubmed/28439950 | ||
| Article | Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments | ||
|---|---|---|---|
| Announcements | J Med Virol. | Date of publication | 2015.02.23 |
| Co-researcher | Cho Y, Lee JH, Yu SJ, Yoon JH, Lee HS, Kim YJ. | ||
| Article | Reduction of oxidative stress attenuates lipoapoptosis exacerbated by hypoxia in human hepatocyts | ||
|---|---|---|---|
| Announcements | Int J Mol Sci. | Date of publication | 2015.02.03 |
| Co-researcher | Hwang SY, Yu SJ, Lee JH, Kim HY, Kim YJ | ||
| Article | Tenofovir Monotherapy versus Tenofovir plus Lamivudine of Telbivudine Combination Therapy in Treatment of Lamivudine-Resistant Chronic Hepatitis B. Antimicrob Agents | ||
|---|---|---|---|
| Announcements | Chemother. | Date of publication | 2015.02 |
| Co-researcher | Lee YB, Jung EU, Kim BH, Lee JH, Cho H, Ahn H, Choi WM, Cho YY, Lee M, Yoo JJ, Cho Y, Lee DH, Cho EJ, Yu SJ, Park SJ, Kim YJ, Park JW, Lee YJ, Kim CM, Yoon JH, Kim CY, Lee HS | ||
| Article | Forns ndex predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection | ||
|---|---|---|---|
| Announcements | Liver Int. | Date of publication | 2015.01.02 |
| Co-researcher | Choi WM, Lee JH, Ahn H, Cho H, Cho YY, Lee YY, Lee M, Yoo JJ, Cho Y, Lee DH, Lee YB, Cho EJ, Yu SJ, Yi NJ, Lee KW, Kim YJ, Yoon JH, Suh KS, Kim CY, Lee HS | ||
| Article | CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis | ||
|---|---|---|---|
| Announcements | Liver Int. | Date of publication | 2015.01 |
| Co-researcher | Lee M, Lee JH, Oh S, Jang Y, Lee W, Lee HJ, Yoo JJ, Choi WM, Cho YY, Cho Y, Lee DH, Lee YB, Yu SJ, Yi NJ, Lee KW, Kim YJ, Yoon JH, Suh KS, Lee HS | ||
| Article | JNK signaling in hepatocarcinoma cells is associated with the side population upon treatment with anticancer drugs | ||
|---|---|---|---|
| Announcements | Mol Med Rep. | Date of publication | 2015.01 |
| Co-researcher | Kim JB, Park SY, Kim HR, Ahn YH, Jee HG, Lee JH, Yu SJ, Lee HS, Lee M, Yoon JH, Kim YJ | ||
| Article | Non-hypervascular hepatobiliary phase Hypointense Nodules on Gadoxetic Acid-enhanced MRI: Risk of HCC Recurrence after Radiofrequency Ablation | ||
|---|---|---|---|
| Announcements | J Hepatol. | Date of publication | 2014.12.17 |
| Co-researcher | Lee DH, Lee JM, Lee JY, Kim SH, Kim JH, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK, Choi BI. | ||
| Article | Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication | ||
|---|---|---|---|
| Announcements | J Viral Hepat. | Date of publication | 2014.12 |
| Co-researcher | Yu SJ, Kim JW, Lee JH, Yoon JH, Lee HS, Cheong JY, Cho SW, Shin HD, Kim YJ | ||
| Article | Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases | ||
|---|---|---|---|
| Announcements | PLoS One. | Date of publication | 2014.11.26 |
| Co-researcher | Yoo JJ, Lee JH, Lee SH, Lee M, Lee DH, Cho Y, Lee YB, Yu SJ, Kim HC, Kim YJ, Yoon JH, Kim CY, Lee HS | ||
| Article | Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains | ||
|---|---|---|---|
| Announcements | Antimicrob Agents Chemother. | Date of publication | 2014.11 |
| Co-researcher | Lee YB, Lee JH, Lee DH, Cho H, Ahn H, Choi WM, Cho YY, Lee M, Yoo JJ, Cho Y, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Kim CY, Lee HS | ||
| Article | Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy | ||
|---|---|---|---|
| Announcements | J Viral Hepat. | Date of publication | 2014.11 |
| Co-researcher | Lee M, Oh S, Lee HJ, Yeum TS, Lee JH, Yu SJ, Kim HY, Yoon JH, Lee HS, Kim YJ. | ||
| Article | Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population | ||
|---|---|---|---|
| Announcements | Liver Int. | Date of publication | 2014.11 |
| Co-researcher | Cheong HS, Lee JH, Yu SJ, Yoon JH, Lee HS, Cheong JY, Cho SW, Park NH, Park BL, Namgoong S, Kim LH, Shin HD, Kim YJ. | ||
| Article | A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase | ||
|---|---|---|---|
| Announcements | Korean J Intern Med. | Date of publication | 2014.09 |
| Co-researcher | Yu SJ, Won JK, Ryu HS, Choi WM, Cho H, Cho EJ, Lee JH, Kim YJ, Suh KS, Jang JJ, Kim CY, Lee HS, Yoon JH, Cho KH | ||
| Article | Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma? | ||
|---|---|---|---|
| Announcements | PLoS One. | Date of publication | 2014.08 |
| Co-researcher | Cho Y, Lee DH, Lee YB, Lee M, Yoo JJ, Choi WM, Cho YY, Paeng JC, Kang KW, Chung JK, Yu SJ, Lee JH, Yoon JH, Lee HS, Kim YJ | ||
| Article | Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis | ||
|---|---|---|---|
| Announcements | PLoS One | Date of publication | 2014.07 |
| Co-researcher | Lee M, Kim W, Choi Y, Kim S, Kim D. Yu SJ, Lee JH, Kim HY, Jung YJ, Kim BG, Kim YJ, Yoon JH, Lee KL, Lee HS | ||
| Article | Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet | ||
|---|---|---|---|
| Announcements | Dig Dis Sci. | Date of publication | 2014.07 |
| Co-researcher | Cho EJ, Yoon JH, Kwak MS, Jang ES, Lee JH, Yu SJ, Kim YJ, Kim CY, Lee HS | ||
| Article | High sensitivity C-reactive protein level is an independent predictor of poor prognosis in cirrhotic patients with spontaneous bacterial peritonitis | ||
|---|---|---|---|
| Announcements | J Clin Gastroenterol. | Date of publication | 2014.05 ~ 2014.06 |
| Co-researcher | Cho Y, Park SY, Lee JH, Lee DH, Lee M, Yoo JJ, Choi WM, Cho YY, Lee YB, Yoon JW, Kwon JH, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Kim CY, Lee HS | ||
| Article | Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization | ||
|---|---|---|---|
| Announcements | PLoS One. | Date of publication | 2014.03.04 |
| Co-researcher | Yu SJ, Kim YJ, Yoon JH, Chung JW, Kim CY, Lee HS | ||
| Article | Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta-analysis | ||
|---|---|---|---|
| Announcements | J Viral Hepat. | Date of publication | 2014.03 |
| Co-researcher | Lee DH, Lee JH, Kim YJ, Park NH, Cho Y, Lee YB, Yoo JJ, Lee M, Cho YY, Cho WM, Yu SJ, Yoon JH, Kim CY, Lee HS | ||
| Article | Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence | ||
|---|---|---|---|
| Announcements | Endocr Relat Cancer. | Date of publication | 2014.02.07 |
| Co-researcher | Lee SB, Jeong H, Kim CY, Lee HS | ||
| Article | Side population in LX2 cells decreased by transforming growth factor-β | ||
|---|---|---|---|
| Announcements | Hepatol Res. | Date of publication | 2014.02 |
| Co-researcher | Kim JB, Ann YH, Park SY, Lee HG, Kim HR, Lee JH, Yu SJ, Lee HS, Kim YJ | ||
| Article | Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis | ||
|---|---|---|---|
| Announcements | Eur J Clin Microbiol Infect Dis. | Date of publication | 2014.02 |
| Co-researcher | Hwang SY, Yu SJ, Lee JH, Kim JS, Yoon JW, Kim YJ, Yoon JH, Kim EC, Lee HS | ||
| Article | Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance | ||
|---|---|---|---|
| Announcements | Antimicrob Agents Chemother | Date of publication | 2014 |
| Co-researcher | Lee JH, Cho Y, Lee DH, Lee M, Yoo JJ, Choi WM, Cho YY, Lee YB, Yu SJ, Yoon JH, Lee HS, Kim YJ. | ||
| Article | Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor Kappa B activation and inducing apoptosis | ||
|---|---|---|---|
| Announcements | J Gastroenterol Hepatol. | Date of publication | 2013.12 |
| Co-researcher | Kim BH, Yoon JH, Yang JI, Myung SJ, Lee HJ, Jung EU, Yu SJ, Kim YJ, Lee HS, Kim CY | ||
| Article | A genome-wide association study identified new variants associated with the risk of chronic hepatitis B | ||
|---|---|---|---|
| Announcements | Hum Mol Genet. | Date of publication | 2013.10.15 |
| Co-researcher | Kim YJ, Kim HY, Lee JH, Yu SJ, Yoon JH, Lee HS, Kim CY, Cheong JY, Cho SW, Park NH, Park BL, Namgoong S, Kim LH, Cheong HS, Shin HD | ||
| Article | Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK | ||
|---|---|---|---|
| Announcements | J Biol Chem. | Date of publication | 2013.10.04 |
| Co-researcher | Kim HD, Yu SJ, Kim HS, Kim YJ, Choe JM, Park YG, Kim J, Sohn J | ||
| Article | Hepatitis B viral load effects prognosis of hepatocellular carcinoma | ||
|---|---|---|---|
| Announcements | World J Jastroenterol. | Date of publication | 2013.09.14 |
| Co-researcher | Yu SJ, Kim YJ. | ||
| Article | Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting | ||
|---|---|---|---|
| Announcements | Radiology. | Date of publication | 2013.06 |
| Co-researcher | Yang HJ, Lee JH, Lee DH, Yu SJ, Kim YJ, Yoon JH, Kim HC, Lee JM, Chang JW, Yi NJ, Lee KW, Suh KS, Lee HS | ||
| Article | The efficacy of adefovir plus entecavir combination therapy in patients with chronic hepatitis B refractory to both lamivudine and adefovir | ||
|---|---|---|---|
| Announcements | Dig Dis Sci | Date of publication | 2013 |
| Co-researcher | Cho Y, Lee DH, Chung KH, Jin E, Lee JH, Cho EJ, Yu SJ, Kim JW, Jeong SH, Yoon JH, Lee HS, Kim CY, Kim YJ | ||
| Article | Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization | ||
|---|---|---|---|
| Announcements | J Cancer Res Clin Oncol | Date of publication | 2013 |
| Co-researcher | Jang ES, Yoon JH, Chung JW, Cho EJ, Yu SJ, Lee JH, Kim YJ, Lee HS, Kim CY | ||
| Article | Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation | ||
|---|---|---|---|
| Announcements | Liver Int | Date of publication | 2013 |
| Co-researcher | Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS | ||
| Article | Serum Insulin-Like Growth Factor-1 Level Is an Independent Predictor of Recurrence and Survival in Early Hepatocellular Carcinoma: A Prospective Cohort Study | ||
|---|---|---|---|
| Announcements | Clin Cancer Res | Date of publication | 2013 |
| Co-researcher | Cho EJ, Lee JH, Yoo JJ, Choi WM, Lee MJ, Cho Y, Lee DH, Lee YB, Kwon JH, Yu SJ, Lee JM, Suh KS, Kim K, Kim YJ, Yoon JH, Kim CY, Lee HS | ||
| Article | Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization | ||
|---|---|---|---|
| Announcements | Radiology | Date of publication | 2013 |
| Co-researcher | Yu SJ, Lee JH, Jang ES, Cho EJ, Kwak MS, Yoon JH, Lee HS, Kim CY, Kim YJ | ||
| Article | "Simple Scoring System Predicting Genotypic Resistance During Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B | ||
|---|---|---|---|
| Announcements | J Clin Gastroenterol | Date of publication | 2012 |
| Co-researcher | Lee JH, Yoon JH, Cho EJ, Yang HJ, Jang ES, Kwak MS, Hwang SY, Yu SJ, Lee CH, Kim YJ, Kim CY, Lee HS | ||
| Article | Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition | ||
|---|---|---|---|
| Announcements | J Bioenerg Biomembr | Date of publication | 2012 |
| Co-researcher | Yu SJ, Yoon JH, Yang JI, Cho EJ, Kwak MS, Jang ES, Lee JH, Kim YJ, Lee HS, Kim CY | ||
| Article | Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth | ||
|---|---|---|---|
| Announcements | Oncol Rep | Date of publication | 2011 |
| Co-researcher | Chung GE, Yoon JH, Lee JH, Kim HY, Myung SJ, Yu SJ, Lee SH, Lee SM, Kim YJ, Lee HS | ||
| Article | Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis | ||
|---|---|---|---|
| Announcements | Acta Pharmacol Sin | Date of publication | 2011 |
| Co-researcher | Yu SJ, Yoon JH, Lee JH, Myung SJ, Jang ES, Kwak MS, Cho EJ, Jang JJ, Kim YJ, Lee HS | ||
| Article | Mesalamine-induced B7-H1 expression on hepatic stellate cells attenuates autoimmune liver injury | ||
|---|---|---|---|
| Announcements | Hepatol Res | Date of publication | 2011 |
| Co-researcher | Lee JH, Yoon JH, Lee YJ, Yang JI, Kwak MS, Cho EJ, Jang ES, Yu SJ, Choi DH, Jung EU, Kim HY, Kim BH, Chung GE, Kim YJ, Jang JJ, Kim CY, Lee HS | ||
| Article | Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma | ||
|---|---|---|---|
| Announcements | J Clin Gastroenterol | Date of publication | 2011 |
| Co-researcher | Lee JH, Chung GE, Yu SJ, Hwang SY, Kim JS, Kim HY, Yoon JH, Lee HS, Yi NJ, Suh KS, Lee KU, Jang JJ, Kim YJ | ||
| Article | TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence | ||
|---|---|---|---|
| Announcements | Dig Dis | Date of publication | 2011 |
| Co-researcher | Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, Bae JS, Lee HS, Shin HD, Kim YJ | ||
| Article | Validation of P2/MS and Other Noninvasive Fibrosis Scoring Systems in the Korean Population with Nonalcoholic Fatty liver Disease | ||
|---|---|---|---|
| Announcements | Korean J Gastroenterol | Date of publication | 2011 |
| Co-researcher | Yu SJ, Kim DH, Lee JH, Chung GE, Yim JY, Park MJ, Kim YJ, Yoon JH, Jang JJ, Lee HS. | ||
| Article | Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy | ||
|---|---|---|---|
| Announcements | Hepatogastroenterology | Date of publication | 2011 |
| Co-researcher | Kwak MS, Lee JH, Chung GE, Yu SJ, Jung EU, Kim BH, Choi DH, Kim HY, Kim SH, Lee JM, Lee JY, Kim YJ, Yoon JH, Lee HS | ||
| Article | Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma | ||
|---|---|---|---|
| Announcements | Korean J Hepatol | Date of publication | 2010.12 |
| Co-researcher | Yu SJ, Lee JH, Chung GE, Lee CH, Cho EJ, Jang ES, Kwak MS, Kim YJ, Yoon JH, Jang JJ, Lee HS | ||
| Article | Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells | ||
|---|---|---|---|
| Announcements | Cancer Lett | Date of publication | 2010.12 |
| Co-researcher | Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, Myung SJ, Kim YJ, Lee HS | ||
| Article | Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells | ||
|---|---|---|---|
| Announcements | Cancer Lett | Date of publication | 2010. 9 |
| Co-researcher | Lee JH, Yoon JH, Yu SJ, Chung GE, Jung EU, Kim HY, Kim BH, Choi DH, Myung SJ, Kim YJ, Kim CY, Lee HS | ||
| Article | Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth | ||
|---|---|---|---|
| Announcements | Cancer Lett | Date of publication | 2008. 11 |
| Co-researcher | Park SC, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, Suh KS, Lee HS | ||
| Article | Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients. | ||
|---|---|---|---|
| Announcements | Hepatogastroenterology | Date of publication | 2007 |
| Co-researcher | Gwak GY, Kim TH, Yu SJ, Yoon JH, Yong JJ, Park SC, Lee HS | ||
| Article | A case of infiltrative hepatocellular carcinoma with main portal vein tumor thrombosis successfully treated by transarterial chemoembolization | ||
|---|---|---|---|
| Announcements | Korean J Hepatol | Date of publication | 2006 |
| Co-researcher | Myung SJ, Yoon JH, Gwak GY, Shin CM, Ahn DW, Yu SJ, Yu JW, Cho SJ, Chung JW, Lee HS | ||
| Article | Anti-apoptotic N-cadherin signaling and its prognostic implication in human hepatocellular carcinoma | ||
|---|---|---|---|
| Announcements | Oncol Rep | Date of publication | 2006 |
| Co-researcher | Gwak GY, Yoon JH, Yu SJ, Park SC, Jang JJ, Lee KB, Lee SH, Lee SM, Shin CS, Suh KS, Lee HS | ||
| Article | Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy | ||
|---|---|---|---|
| Announcements | Jpn J Clin Oncol | Date of publication | 2004 |
| Co-researcher | Lee JJ, Kim TM, Yu SJ, Kim DW, Joh YH, Oh DY, Kwon JH, Kim TY, Heo DS, Bang YJ, Kim NK | ||